We studied the localization of the epidermal growth factor (EGF) in eccrine and apocrine sweat glands with light microscopic and electron microscopic immunohistochemistry.
Introduction
The human body possesses 3-4 x lo6 sweat glands, two types of which are generally recognized, i.e., eccrine and apocrine sweat glands. Eccrine sweat glands, smaller than apocrine sweat glands, are distributed all over the body surface. Their main function is the control of body temperature. The secretory portion of eccrine sweat glands consists of three types of cells: clear cells, dark cells, and myoepithelial cells. On the other hand, apocrine sweat glands, the larger sweat glands, are distributed mainly on the axillary and genital skin. They are a remnant of an odorous organ. The secretory portion of apocrine glands consists of secretory cells and myoepithelial cells (1.2). Although eccrine sweat consists mainly of water and electrolytes, recent studies show that it contains proteolytic enzymes, glycoproteins, and human epidermal growth factor (hEGF), among others (2) .
Epidermal growth factor (EGF) is a polypeptide which Cohen (3) initially isolated from the submaxillary glands of male mice. The gastric anti-secretory hormone urogastrone, found in human urine, is considered analogous to hEGF because it has a very simi- mitochondrion-like intemal structure. No reactivity was observed on the eccrine secretory cells by immunoelecuon microscopy. Neither dark cell granules nor mitochondria in eccrine secretory cells were labeled with anti-hEGF antibody. In both eccrine and apocrine sweat glands, hEGF-like immunoreactivity was difhsely present in the cytoplasm of myoepithelial cells. However, nuclei and mitochondria of myoepithelial cells were devoid of immunoreactivity for hEGF. Our observations indicate that apocrine sweat glands may secrete more hEGF in the sweat than eccrine sweat glands.
( J Hisrochem Cyrochem 40:241-249, 1992)
KEY WORDS: Epidermal growth factor; Sweat glands; Immunocytochemistry; Electron microscopy; Human. lar amino acid sequence and biological activities identical to those of mouse EGF. Available data show that hEGF and mouse EGF are very similar but not identical with respect to their chemical and physical properties. Both peptides exhibit the same biological activities and have some common antigenic sites (4,5). Although hEGF is present in various secretory fluids, including sweat, little is known about its localization in sweat glands or the cellular mechanism of secretion into sweat (6) . Recently, Sat0 and co-workers (2,7) confirmed that hEGF is indeed present in human sweat collected with precautions to minimize epidermal contamination. Their studies showed that thermally induced axillary sweat contains 50 times more EGF than sweat obtained from other areas of the trunk. The purpose of the present study was to determine if hEGF is present in the sweat glands and, if so, in which sweat glands and in what portion of them.
Materials and Methods

Light Microscopic Immunohistochemistry with Polyclonal Antibody.
Skin samples were obtained from the margins of surgical specimens. Six specimens from trunks and limbs were used for eccrine sweat glands and four specimens from axillary skin were used for apocrine sweat glands. Light microscopic immunohistochemistry using anti-hEGF antiserum was carried out as follows. The tissue was fied in buffered 10% formalin for 2 days, followed by embedding in paraffin in the routine manner. Five-wm sec-
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SAGA, TAKAHASHI tions were cut and mounted on glass slides, followed by deparaffinization in xylene and rehydration. Endogenous peroxidase was blocked by incubating the rehydrated sections in 0.3% H202 in methanol for 20 min. The primary antiserum (1:400) was applied on the slides and incubated overnight at 4'C in a moist chamber. After washing in PBS. biotinylated anti-rabbit IgG was applied and incubated for 30 min at room temperature. The slides were washed in PBS. Streptavidin-peroxidase conjugate was applied on the sections and incubated for 30 min. followed by washing in PBS. Color development took place in 0.03% diaminobenzidine and 0.01% H202 in 0.05 M Tris-HCI buffer, pH 7.2, at room temperature for 2 min. The primary antiserum was raised in rabbits by injecting highly purified recombinant hEGF as a source antigen. This antiserum formed an immunoprecipitation line with purified hEGF by a double immunodiffusion technique (8). and did not crossreact with mouse EGF by radioimmunoassay (manufacturer's data sheet).
Light Microscopic Immunohistochemistry with Monoclonal Antibody. Tissue for light microscopic immunohistochemistry using an anti-hEGF monoclonal antibody was processed as follows. Small tissue samples were mounted in OCT compound and quickly frozen by immersion in liquid nitrogen. Five-pm frozen sections were cut using a cryostat, then fixed in cold acetone for 10 min. The sections were incubated with the diluted antibody (1:20) overnight at 4°C in a moist chamber. After washing with PBS. the sections were incubated with biotinylated anti-mouse IgG antibody for 30 min. The antibody binding sites were visualized in the same manner as for the polyclonal antiserum by the streptavidin method. The anti-hEGF MAb was made by a hybridoma technique. using recombinant hEGF as an antigen. This antibody specifically reacts with hEGF and does not crossreact with mouse EGF (data sheet from the manufacturer).
Immunoelectron Microscopy. Post-embedding immunocytochemistry was performed by the protein A-gold method. using thin sections from Lowicryl K4M blocks (9) . Small pieces of skin were fixed in a mixture of 3% paraformaldehyde and 0.5% glutaraldehyde in PBS (0.01 M phosphate buffer, pH 7.2) for 1 hr at room temperature. After washing in PBS, the specimens were incubated in 50 mM NH4CI in PBS for 30 min to block aldehyde residue. The specimens were stored in PBS at 4'C overnight. The specimens were dehydrated in the graded series of ethanol and embedded in Lowicryl K4M. The plastic was cured with ultraviolet rays.
Thin sections were cut with a diamond knife and mounted on nickel grids coated with formvar and carbon. The sections were incubated on a drop of the first polyclonal antibody diluted 1230 with PBS. overnight in a moist chamber at 4'C. The sections were washed on 6 drops of PBS and incubated on a drop of protein A-gold, 1:20 dilution, for 1 hr at room temperature. The sections were washed on drops of PBS and water and then stained with 2% uranyl acetate for 8 min. Electron micrographs were taken at an acceleration voltage of 80 kV.
Control Study. As a control study, the sections were stained under the following conditions: (a) the first antibody was omitted from the incubation; (b) antibody was replaced with normal rabbit or mouse serum; and (c) antibodies were absorbed overnight with excess amounts of recombinant hEGF.
Materials. Anti-hEGF polyclonal antiserum was a product of Wakunaga (Osaka, Japan). Anti-hEGF monoclonal antibody and recombinant hEGF were obtained from Ohtsuka Assay (Tokushima, Japan). Lowicryl K4M was obtained from Polyscience (Warrington, PA). Protein A-gold was purchased from Janssen Life Sciences (Beerse, Belgium). The streptavidin immunohistochemistry kit was obtained from BioGenex (Dublin, CA). Other chemicals were reagent grade.
Results
In light microscopic immunohistochemistry with anti-hEGF poly- clonal antiserum, hEGF was localized in the secretory portion of eccrine sweat glands and apocrine sweat glands. In eccrine sweat gland, myoepithelial cells showed strong reactivity, whereas the secretory cells showed weak staining (Figure la) . In apocrine sweat gland, the secretory cells showed reactivity which was as strong as that of myoepithelial cells (Figure 1b) .
Light microscopic immunohistochemistry using anti-hEGF monoclonal antibody applied to frozen sections showed that EGFlike immunoreactivity was localized in the secretory cells and myoepithelial cells of eccrine and apocrine glands. The cytoplasm of apocrine secretory cells facing the lumen showed the strongest reaction ( Figure IC) .
We then performed immunoelectron microscopy because we wanted to know on which organelle EGF was located. Although we tried several furation methods, the monoclonal antibody we used was not reactive to hEGF in post-embedding immunoelectron microscopy. Therefore, we studied the ultrastructural localization of hEGF using polyclonal antiserum. Gold particles were diffusely distributed along with myofilaments in the cytoplasm of myoepithelial cells of both eccrine and apocrine sweat glands (Figures 2 and 3) .
Neither nuclei nor mitochondria of myoepithelial cells showed any reactivity with anti-hEGF antiserum. No reactivity was observed on the eccrine secretory cells by immunoelectron microscopy. Neither dark cell granules nor mitochondria in eccrine secretory cells were labeled with gold particles. In apocrine secretory cells, two types of cytoplasmic granules were recognized. Small granules showed a round to elongated shape and had mitochondrion-like internal structure. Large granules were round and variable in size. Large granules contained fine electrondense particles. Mitochondrion-like small granules showed strong reactivity to hEGF, whereas large granules did not show any labeling (Figures 4 and 5) . Mitochondrion-like granules located in the contraluminal cytoplasm of apocrine secretory cells were smaller than those located in the luminal cytoplasm. These smaller mito-chondrion-like granules in the contraluminal cytoplasm also showed positive staining with the anti-hEGF antibody. We could not find any mitochondrion-like structures without labeling in apocrine secretory cells.
Omission of the first antibody completely abolished the staining in both light and electron microscopic immunohistochemistry. Replacement of the first antibody with normal rabbit serum or normal mouse serum resulted in very low background staining. Absorption of the first antibodies with an excess of recombinant hEGF greatly reduced the staining in light microscopic immunohistochemistry with both polyclonal antiserum and monoclonal antibody. For immunoelectron microscopy, 80 p1 of diluted antise- rum (1:80) was absorbed with 5 wg of recombinant hEGF overnight at 4°C. This absorption resulted in greatly reduced staining in mitochondrion-like apocrine granules and myoepithelial cells in both eccrine and apocrine sweat glands (Figures 6 and 7) .
Discussion
The present study by light and electron microscopic immunocytochemistry showed that immunoreactive EGF was localized in the cytoplasm of eccrine and apocrine sweat glands. The substance detected by these techniques is most likely hEGF, because two different specific antibodies showed a similar distribution and the immunoreactivity was abolished by omitting the first antibodies or was greatly reduced by pre-absorption of the antibodies with recombinant hEGF. However, the failure to detect hEGF in the cytoplasm of both clear and dark cells of eccrine sweat glands by immunoelectron microscopy does not mean that this substance is not present in these cells. The fixation and embedding procedures might have depleted the trace amount of antigenicity present in these cells. The weak reactions to hEGF observed by light microscopic immunohistochemistry suggest that these cells also contain hEGF in their cytoplasm, even if the amount is small.
The main function of human eccrine sweat glands is the control of body temperature, although human sweat consists not only of water and electrolytes but also of various proteolytic enzymes and glycoproteins (10,ll) . Although several reports have demon-strated that human sweat contains hEGF, little is known about the function of hEGF in sweat or the cellular mechanism of its secretion. The presence of hEGF in sweat was first reported by Pesonen et al. (6) , who showed that the concentration of EGF (EGF/unit sweat volume) was much higher in armpit sweat than in breast sweat. Sato and co-workers (2,7) confirmed the presence of EGF in eccrine sweat, using precautions to minimize epidermal contamination during sweat collection. These authors also found that the concentration of EGF in eccrine sweat (EGF/unit sweat volume) increases in proportion to the increase in sweat rate. Interestingly, axillary Sweat contained about 50 times more EGF than back sweat. They speculated that apocrine or apoeccrine glands may be responsible for the high concentration of EGF in the axillae (2,7) . Our immunoelectron microscopic observation supports this speculation. Our data showed that intracytoplasmic granules of apocrine secretory cells were strongly positive for hEGFlike immunoreactivity. Interestingly, the positive reaction was restricted to granules which have the cristae-like internal structure of mitochondria. On the other hand, large granules did not show any immunoreactivity to hEGF. Surprisingly, we could not find any mitochondrion-like structures without labeling with anti-hEGF antibody. This result may indicate either that mitochondria themselves possess hEGFlike antigenicity in apocrine secretory cells or that the number of ordinary mitochondria in apocrine secretory cells is so small that we could not find them.
Cohen first found mEGF in mouse submandibular glands (3) . Many studies demonstrated the presence ofmEGF in secretory granules of the granular convoluted tubule cells in the mouse submandibular gland (12-14). However, the presence of EGF is not confined to the submandibular glands. Kasselberg et al. (15) reported that various human organs, such as anterior pituitary, submandibular gland, stomach, duodenum, bone marrow, lactating mammary gland, trachea, pancreas, adrenal, eccrine sweat gland, kidney, and prostate gland, showed the presence of immunoreactive hEGF at least in some age groups. Nanney et al. (16) studied the localization of EGF receptor in the skin using a [lZSI]-EGF binding method and an immunohistochemical method utilizing anti-EGF receptor monoclonal antibody. Their study revealed that EGF receptors were present in basal epidermal keratinocytes, sebocytes, outer root sheath cells in hair follicles, smooth muscle cells of arrector pili muscles, and dermal arteries. Interestingly, the highest levels of EGF receptors were localized in the dermal ducts of eccrine sweat glands (16). Since horny layers of epidermis would be impermeable to EGF, it is unlikely that EGF in sweat affects the proliferation or the functions of epidermis by binding to the receptors present in basal keratinocytes in non-pathological conditions. However, it is possible that EGF in sweat binds to the receptors present in the basal layers during the process of wound repair and thus facilitates the healing process. Another possibility is that EGF in primary sweat affects the proliferation or the functions of ductal cells, in which a large number of receptors are present. Yet another possibility is that EGF produced by secretory cells controls the proliferation and the functions of secretory cells themselves or of myoepithelial cells by an autocrine or paracrine mode.
Little is known about the physiological significance of EGFlike immunoreactivity in myoepithelial cells. It is most unlikely that the EGF in myoepithelial cells is released into sweat. EGF has been reported to stimulate the activity of Na,K-ATPase in cultured fibroblasts (17). Na,K-ATPase is a key enzyme in the process of sweat secretion and is known to be localized in the basolateral cell membrane facing myoepithelial cells (18) . Myoepithelial cells may interact with secretory cells through EGF to stimulate Na,K-ATPase. An increasing number of reports indicate that EGF receptors are present on myoepithelial cells and various smooth muscle cells, including vaxular smooth muscle, arrector pili muscle, and myometrium (16J9). Recent studies show that EGF stimulates the proliferation and contraction of vascular smooth muscle cells (20). Since myoepithelial cells are rich in EGF receptors, the EGFlike immunoreactivity in these cells shown in our study might have resulted from intemalized EGFreceptor complexes.
Recently, a third type of sweat gland in addition to eccrine and apocrine sweat glands, i.e., an apoeccrine sweat gland, was proposed by Sato's group (21) to be present in axillary skin. These authors showed that the size of apoeccrine sweat glands is intermediate between that of eccrine and apocrine sweat glands. The secretory portion of apoeccrine sweat glands is irregularly dilated. The dilated segment consists of an apocrine-like single layer of epithelium. However, apoeccrine sweat glands open directly to the skin surface, like eccrine glands, instead of to hair follicles, where ordinary apocrine ducts open. The ratio of apoeccrine to eccrine glands in axillary skin for adolescent men and women is almost 1.2. However, in some persons the apoeccrine glands represented less than 10% of the axillary sweat glands (2). We cannot determine if the axillary apocrine-like Sweat glands we studied were ordinary apocrine sweat glands or apoeccrine sweat glands because we do not know the location at which their ducts open. To clardy the type of sweat gland (apocrine or apoeccrine), the gland must be dissected before embedding. However, since our repeated immunohistochemical studies produced consistent results, it is most likely that both apocrine and the dilated segment of apoeccrine sweat glands have a similar distribution of EGF in secretory cells and myoepithelial cells.
